- Location
licensing contract
"-
Japan Tobacco Has Filed a New Drug Application for The Marketing Approval
Jan 9, 2013Japan Tobacco (JT), Keryx Biopharmaceuticals' Japanese partner, has filed a new drug application (NDA) for the marketing approval of Ferric Citrate (Zerenex) in Japan for the treatment of hyperphosphatemia in chronic kidney disease (CKD) ...
Tags: Ferric Citrate, Tobacco, CKD, Pharmaceutical
-
Garmatex Technologies Is Pleased to Announce The Signing of a 5 Year Licensing Contract
Dec 31, 2012VANCOUVER, British Columbia — December 13, 2012 — Garmatex Technologies, Inc. ("Garmatex" or the "Company"), an innovative leader in the research and development of scientifically engineered, performance-inspired fabric ...
Tags: Garmatex Technologies, Textile, protection apparel, apparel
-
The Filing Is Based on a Global Phase III Clinical Development Program
Dec 4, 2012Janssen Research & Development has submitted a new drug application (NDA) to the FDA for canagliflozin to treat adult patients with type 2 diabetes. The filing is based on a global Phase III clinical development program, including nine ...
Tags: Janssen Research&Development, SGLT2, cardiovascular study
-
Cara Therapeutics and Chong Kun Dang Pharmaceutical to Develop and Market CR845
Nov 29, 2012Cara Therapeutics and Chong Kun Dang Pharmaceutical have signed licensing contract to develop and market CR845, an analgesic drug candidate, in the Republic of Korea. As a part of the agreement, Cara is eligible to gain an up-front ...
Tags: analgesic drug candidate, licensing contract, CR845, Cara Therapeutics
-
Mylan Specialty and Pfizer Have Signed Epipen Injection 0.3/0.15mg in Japan
Nov 29, 2012Mylan Specialty, a subsidiary of Mylan, and Pfizer have signed a licensing contract for EpiPen Injection 0.3/0.15mg in Japan. Under the license agreement, Pfizer will have the exclusive rights to market and sell EpiPen Injection ...
Tags: Epipen Injection, epinephrine auto-injector, public health
-
Fresenius Kabi USA Has Announced The Availability of Acetylcysteine Solution, USP
Nov 29, 2012Fresenius Kabi USA has announced the availability of Acetylcysteine Solution, USP, 20% 30ml vial for inhalation (mucolytic agent) or oral administration (acetaminophen antidote) to treat lung diseases. Acetylcysteine Solution, USP, ...
Tags: Acetylcysteine Solution, lung diseases, critical care products
-
HTC and Apple Jointly Released a Statement Yesterday
Nov 12, 2012HTC and Apple jointly released a statement yesterday(Nov.11)saying that both parties have reached a global settlement agreement to eradicate all patent litigations between the two parties and sign a 10-year mutual patent licensing ...
Tags: HTC and Apple, on Patent Dispute, Consumer Electronics
-
Microsoft Confirmed Wednesday That Owners of Windows RT Hardware
Oct 18, 2012Computerworld-Microsoft confirmed Wednesday that owners of Windows RT hardware,including the company's own Surface RT,must acquire a commercial license for Office 2013 to use those devices'bundled Office apps at and for work. The ...
Tags: Windows RT hardware, Microsoft, commercial license, touch-enabled apps
-
Companies Find It Challenging to Remain Compliant with Oracle's Complex Licensing Policies
Oct 10, 2012Companies, including large multinationals that virtualise Oracle databases using VMware products, are finding it challenging to remain compliant with Oracle's complex licensing policies. Such lack of compliance is costing them millions in ...
-
Novaled Has Signed a Purchase and Licensing Contract with Samsung Company
Jul 4, 2012Novaled, a manufacturer of organic light-emitting diode (OLED) products, has signed a purchase and licensing contract with Samsung company (SMD) that provides advanced display solutions. S.I.Cho, President and CEO of Samsung Mobile ...
Tags: OLED Display, LEDs Lighting